You no longer have to see a medical professional to find out your risk of inheriting illness caused by genetic mutations.
The Food and Drug Administration announced Thursday it would reopen the door for third-party companies to sell test kits that tell you your risk of developing an illness like sickle-cell anemia, Parkinson’s, Alzheimer’s, and cystic fibrosis.
The decision reverses a previous ruling that suspended the sale of genetic disease kits sold by 23 and Me, an at-home genetics testing company. The Mountain View-based biotech corporation has been selling its products to Canada and the United Kingdom for years and can again begin to ship its kids out to U.S. customers.
23 and Me offers a number of different services that tell you about your own DNA. The tests previously suspended by the FDA are those that assess the likelihood of developing certain illnesses. The company’s $200 Health+ Wellness package comes with tests for 10 newly approved illness. It plans to submit 100 more for FDA approval in separate installments before the end of the year.
Here is the complete list of approved illness:
Late-onset Alzheimer’s disease
Alpha-1 antitrypsin deficiency
Early-onset primary dystonia
Factor XI deficiency
Goucher illness type 1
Glucose-6-Phosphate Dehydrogenase deficiency